Study author, publication year [reference] | Country | Targeted population | Main parasite species | Drug (n) | Day 1 (odds ratio) | Day 2 (odds ratio) | Day 3 (odds ratio) |
---|---|---|---|---|---|---|---|
Hombhanje et al., 2009 [19] | PNG | Adults | P. falciparum | ASNQ (51) | 94 % | 99.8 % | 99.95 % |
CQSP (49) | 79 % (1.18) | 99.3 % (≈1.0) | 99.7 % (≈1.0) | ||||
Rujumba et al., 2010 [20] | Uganda | Children | P. falciparum | ASNQ | NA | 100 % | NA |
AL | 100 % (1.0) | ||||||
Kinde-Gazard et al., 2012a [21] | Benin | Children | P. falciparum | ASNQ (84) | 98 % | 100 % | 99.5 % |
AL (90) | 96 % (1.02) | 99 % (1.02) | 100 % (1.01) | ||||
Tjitra et al., 2012b [22] | Indonesia | Adults | P. falciparum | ASNQ (201) | 70 % | 98 % | 100 % |
DHP (201) | 58 % (1.2) | 98 % (1.0) | 100 % (1.0) |